Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.62/Share
Go back to Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.62/Share| (NASDAQ: ACRS) | Delayed: 4.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.92 | 52 Week High | $33.88 | |||
| Open | $4.92 | 52 Week Low | $14.12 | |||
| Day High | $4.92 | P/E | N/A | |||
| Day Low | $4.92 | EPS | $0.00 | |||
| Volume | 15 | |||||

